Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Adam Laponis, CFO of Twist Bioscience, sold 918 shares of common stock on February 21, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 21, 2025, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 918 shares of the company's common stock.
- The sale was executed at a price of $44.177 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Laponis directly owns 109,496 shares of Twist Bioscience Corp.
- The reported transaction includes shares acquired under the Issuer's Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't indicate any particularly positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date of stock sale transaction. |
| 02/25/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.